CNR1 and atherosclerosis: Intriguingly, the effects mediated by cannabinoids via their receptors in atherosclerosis are opposite: activation of CB1R is closely associated with multiple cardiometabolic risk factors [38, 39], whereas activation of CB2R in immune cells shows protective and anti-inflammatory effects [11,15].